Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chronic Pain × Botulinum Toxins, Type A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5 Neoplasms 3 Prostatic Neoplasms 2 Pain, Postoperative 2 Pain 2 Breast Diseases 2 Wounds and Injuries 1 Stroke 1 Stomach Neoplasms 1 Spinal Cord Injuries 1 Skin Diseases 1 Rectal Neoplasms 1 Prostatic Hyperplasia 1 Pancreatic Neoplasms 1 Neuroma 1 Neoplasms by Site 1 Muscular Atrophy 1 Muscle Spasticity 1 Lower Urinary Tract Symptoms 1 Low Anterior Resection Syndrome 1 Hereditary leiomyomatosis and renal cell cancer 1 Head and Neck Neoplasms 1 Gastroparesis 1 Ganglion Cysts 1 Esophageal Neoplasms 1 Esophageal Motility Disorders 1 Esophageal Diseases 1 Esophageal Achalasia 1 Cluster Headache 1 Chronic Pain 1

Interventions

Morphine 7 Ketamine 5 Fentanyl 4 Sodium Chloride 3 Saline Solution 3 Lidocaine 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 Surveys and Questionnaires 2 Pregabalin 2 Mindfulness-Based Stress Reduction 2 Hypnosis 2 Bupivacaine 2 Acetaminophen 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Tramadol 1 Therapeutics 1 Telemedicine 1 Tea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01374191 2015-08-26

Botulinum Toxin Type A for Neuroma Pain

Southern Illinois University

Phase 2 Withdrawn

Neuroma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡